Neill Gingles has spent over 25 years working in academia, pharmaceutical and biotech SME industries. He has experience working in various therapy areas such as infectious disease, cardiovascular disease and oncology from preclinical early development through to late stage and marketed products. He has recently joined MDC in November 2019 within the preclinical imaging team.
